ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,611 Cr | ₹1,521 Cr | ₹1,411 Cr | ₹1,260 Cr | ₹1,149 Cr |
What is the latest Total Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,611 Cr |
| Mar2024 | ₹1,521 Cr |
| Mar2023 | ₹1,411 Cr |
| Mar2022 | ₹1,260 Cr |
| Mar2021 | ₹1,149 Cr |
How is Total Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,611 Cr | 5.91 | |
| Mar2024 | ₹1,521 Cr | 7.85 | |
| Mar2023 | ₹1,411 Cr | 11.93 | |
| Mar2022 | ₹1,260 Cr | 9.65 | |
| Mar2021 | ₹1,149 Cr | - | |
Compare Total Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,399.5 Cr | -2% | -2.1% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,753.0 Cr | -0.2% | 6.1% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,998.0 Cr | -1.4% | -4.9% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,186.0 Cr | 0.8% | 5% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,960.0 Cr | -1.3% | -0.5% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,759.0 Cr | -0.7% | 5.1% | 4.9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2% |
-2.1% |
-17.9% |
| SENSEX | -0.6% |
2.2% |
5.3% |
You may also like the below Video Courses